ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
89 hedge funds and large institutions have $426M invested in Endocyte, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 15 closing their positions.
Holders
89
Holders Change
+18
Holders Change %
+25.35%
% of All Funds
2.04%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
33
Increased
27
Reduced
14
Closed
15
Calls
$4.91M
Puts
$3.19M
Net Calls
+$1.73M
Net Calls Change
+$2.78M
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$51.8M |
| 2 |
VMI
2
VHCP Management II
New York
|
$39.1M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$28.3M |
| 4 |
DM
4
Deerfield Management
New York
|
$23.9M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$20M |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$3.66M |
| 2 |
2
D.E. Shaw & Co
New York
|
$14.7M |
| 3 |
3
Millennium Management
New York
|
$1.72M |
| 4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$1.59M |
| 5 |
5
Renaissance Technologies
New York
|
$1.77M |
